Krystal Biotech, Inc.
KRYSNasdaqCIK 1711279HealthcareFiscal year ends Dec 31
Reports and events: 160 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1507:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001711279-26-000064 |
| 2026-08-0307:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001711279-26-000058 |
| 2026-08-0307:03 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001711279-26-000057 |
| 2026-07-2117:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001711279-26-000050 |
| 2026-05-2020:08 ET | 8-K | 5.07 Shareholder vote results | 0001711279-26-000047 |
| 2026-05-0407:07 ET | 8-K | 9.01 Financial statements and exhibits | 0001711279-26-000044 |
| 2026-05-0407:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001711279-26-000043 |
| 2026-04-0316:31 ET | DEF 14A | Proxy statementPeriod 2026-04-03 | 0001711279-26-000036 |
| 2026-02-1707:06 ET | 8-K | 2.02 Results of operations | 0001711279-26-000018 |
| 2026-02-1707:05 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001711279-26-000016 |
| 2026-01-1207:50 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001711279-26-000008 |
| 2026-01-0816:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001711279-26-000005 |
| 2025-12-2316:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001711279-25-000092 |
| 2025-11-0307:04 ET | 8-K | 2.02 Results of operations | 0001711279-25-000088 |
| 2025-11-0307:03 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001711279-25-000087 |
| 2025-10-2208:01 ET | 8-K | 8.01 Other events | 0001711279-25-000082 |
| 2025-08-0407:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001711279-25-000078 |
| 2025-08-0407:04 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001711279-25-000077 |
| 2025-07-2509:03 ET | 8-K | 7.01 Regulation FD disclosure | 0001711279-25-000071 |
| 2025-07-2416:45 ET | 8-K | 7.01 Regulation FD disclosure | 0001711279-25-000069 |
| 2025-07-0909:01 ET | 8-K | 7.01 Regulation FD disclosure | 0001711279-25-000065 |
| 2025-06-0217:12 ET | 8-K | 8.01 Other events | 0001711279-25-000055 |
| 2025-05-1917:06 ET | 8-K | 5.07 Shareholder vote results | 0001711279-25-000051 |
| 2025-05-1318:31 ET | 8-K | 7.01 Regulation FD disclosure | 0001711279-25-000048 |
| 2025-05-0608:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001711279-25-000045 |
| 2025-05-0608:08 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001711279-25-000044 |
| 2025-05-0618:58 ET | 8-K | 7.01 Regulation FD disclosure | 0001711279-25-000037 |
| 2025-04-2808:53 ET | 8-K | 7.01 Regulation FD disclosure | 0001711279-25-000029 |
| 2025-04-0316:38 ET | DEF 14A | Proxy statementPeriod 2025-04-03 | 0001711279-25-000021 |
| 2025-02-2816:53 ET | 8-K | 9.01 Financial statements and exhibits | 0001711279-25-000013 |
| 2025-02-1907:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001711279-25-000009 |
| 2025-02-1907:19 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001711279-25-000008 |
| 2024-12-1808:39 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001711279-24-000065 |
| 2024-12-1208:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001711279-24-000062 |
| 2024-11-0408:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001711279-24-000056 |
| 2024-11-0408:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001711279-24-000055 |
| 2024-08-2816:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001711279-24-000045 |
| 2024-08-0508:08 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001711279-24-000040 |
| 2024-08-0508:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001711279-24-000038 |
| 2024-05-2116:38 ET | 8-K | 5.07 Shareholder vote results | 0001711279-24-000027 |
| 2024-05-0819:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001711279-24-000023 |
| 2024-05-0608:17 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001711279-24-000020 |
| 2024-05-0608:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001711279-24-000018 |
| 2024-04-0416:08 ET | DEF 14A | Proxy statementPeriod 2024-04-04 | 0001711279-24-000013 |
| 2024-02-2608:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001711279-24-000009 |
| 2024-02-2607:49 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001711279-24-000005 |
| 2023-11-0607:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001711279-23-000074 |
| 2023-11-0607:08 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001711279-23-000073 |
| 2023-08-0708:18 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001711279-23-000069 |
| 2023-08-0707:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001711279-23-000067 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:54 ET. Listed shows no prices and gives no investment advice.